{"count":221304,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1660","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1658","results":[{"created":"2020-08-23T19:05:27.339861+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.61","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: PNPO was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"PNPO","entity_type":"gene"},{"created":"2020-08-23T19:05:03.685934+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.60","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: PNPO: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Pyridoxamine 5'-phosphate oxidase deficiency, MIM# 610090; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"PNPO","entity_type":"gene"},{"created":"2020-08-23T19:00:01.139280+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.60","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PCBD1 as ready","entity_name":"PCBD1","entity_type":"gene"},{"created":"2020-08-23T19:00:01.128841+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.60","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pcbd1 has been classified as Amber List (Moderate Evidence).","entity_name":"PCBD1","entity_type":"gene"},{"created":"2020-08-23T18:59:58.604212+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.60","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: PCBD1 were changed from  to Hyperphenylalaninemia, BH4-deficient, D, MIM# 264070","entity_name":"PCBD1","entity_type":"gene"},{"created":"2020-08-23T18:59:22.187042+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.59","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: PCBD1 were set to ","entity_name":"PCBD1","entity_type":"gene"},{"created":"2020-08-23T18:59:01.865668+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.58","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: PCBD1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"PCBD1","entity_type":"gene"},{"created":"2020-08-23T18:58:41.392957+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.57","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: PCBD1 as Amber List (moderate evidence)","entity_name":"PCBD1","entity_type":"gene"},{"created":"2020-08-23T18:58:41.381147+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.57","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pcbd1 has been classified as Amber List (Moderate Evidence).","entity_name":"PCBD1","entity_type":"gene"},{"created":"2020-08-23T18:58:15.302671+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.56","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: PCBD1: Rating: AMBER; Mode of pathogenicity: None; Publications: 9585615; Phenotypes: Hyperphenylalaninemia, BH4-deficient, D, MIM# 264070; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"PCBD1","entity_type":"gene"},{"created":"2020-08-23T18:53:56.340655+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2867","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MAOA as ready","entity_name":"MAOA","entity_type":"gene"},{"created":"2020-08-23T18:53:56.332661+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2867","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: maoa has been classified as Green List (High Evidence).","entity_name":"MAOA","entity_type":"gene"},{"created":"2020-08-23T18:53:52.563451+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2867","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MAOA were changed from  to Brunner syndrome, MIM# 300615","entity_name":"MAOA","entity_type":"gene"},{"created":"2020-08-23T18:53:24.105945+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2866","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: MAOA were set to ","entity_name":"MAOA","entity_type":"gene"},{"created":"2020-08-23T18:53:00.685156+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2865","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MAOA was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"MAOA","entity_type":"gene"},{"created":"2020-08-23T18:52:22.606847+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.2864","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MAOA: Rating: GREEN; Mode of pathogenicity: None; Publications: 25807999, 24169519; Phenotypes: Brunner syndrome, MIM# 300615; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"MAOA","entity_type":"gene"},{"created":"2020-08-23T18:51:35.274929+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3911","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MAOA as ready","entity_name":"MAOA","entity_type":"gene"},{"created":"2020-08-23T18:51:35.266541+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3911","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: maoa has been classified as Green List (High Evidence).","entity_name":"MAOA","entity_type":"gene"},{"created":"2020-08-23T18:51:10.206520+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3911","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MAOA were changed from  to Brunner syndrome, MIM# 300615","entity_name":"MAOA","entity_type":"gene"},{"created":"2020-08-23T18:50:51.424005+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3910","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: MAOA were set to ","entity_name":"MAOA","entity_type":"gene"},{"created":"2020-08-23T18:50:32.591095+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3909","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MAOA was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"MAOA","entity_type":"gene"},{"created":"2020-08-23T18:50:14.176965+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3908","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MAOA: Rating: GREEN; Mode of pathogenicity: None; Publications: 25807999, 24169519; Phenotypes: Brunner syndrome, MIM# 300615; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"MAOA","entity_type":"gene"},{"created":"2020-08-23T18:49:16.177875+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.56","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MAOA as ready","entity_name":"MAOA","entity_type":"gene"},{"created":"2020-08-23T18:49:16.169431+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.56","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: maoa has been classified as Green List (High Evidence).","entity_name":"MAOA","entity_type":"gene"},{"created":"2020-08-23T18:49:13.949082+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.56","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MAOA were changed from  to Brunner syndrome, MIM# 300615","entity_name":"MAOA","entity_type":"gene"},{"created":"2020-08-23T18:48:46.158618+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.55","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: MAOA were set to ","entity_name":"MAOA","entity_type":"gene"},{"created":"2020-08-23T18:48:19.725488+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.54","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MAOA was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"MAOA","entity_type":"gene"},{"created":"2020-08-23T18:47:55.181923+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.53","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MAOA: Rating: GREEN; Mode of pathogenicity: None; Publications: 25807999, 24169519; Phenotypes: Brunner syndrome, MIM# 300615; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"MAOA","entity_type":"gene"},{"created":"2020-08-23T18:44:39.419593+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.53","user_name":"Zornitza Stark","item_type":"entity","text":"changed review comment from: Well established gene-disease association, but indirect link to neurotransmitter defects: gephryn interacts with glycine and GABA receptors.; to: Indirect link to neurotransmitter defects: gephryn interacts with glycine and GABA receptors.","entity_name":"GPHN","entity_type":"gene"},{"created":"2020-08-23T18:43:55.690855+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.53","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GPHN as ready","entity_name":"GPHN","entity_type":"gene"},{"created":"2020-08-23T18:43:55.682688+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.53","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gphn has been classified as Red List (Low Evidence).","entity_name":"GPHN","entity_type":"gene"},{"created":"2020-08-23T18:35:55.844071+10:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.796","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GPHN as ready","entity_name":"GPHN","entity_type":"gene"},{"created":"2020-08-23T18:35:55.833930+10:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.796","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gphn has been classified as Green List (High Evidence).","entity_name":"GPHN","entity_type":"gene"},{"created":"2020-08-23T18:35:51.813805+10:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.796","user_name":"Zornitza Stark","item_type":"entity","text":"Tag SV/CNV tag was added to gene: GPHN.","entity_name":"GPHN","entity_type":"gene"},{"created":"2020-08-23T18:35:44.429935+10:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.796","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GPHN were changed from  to Molybdenum cofactor deficiency C, MIM# 615501; Epilepsy; Autism; Intellectual disability","entity_name":"GPHN","entity_type":"gene"},{"created":"2020-08-23T18:35:23.007477+10:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.795","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GPHN were set to ","entity_name":"GPHN","entity_type":"gene"},{"created":"2020-08-23T18:35:00.840095+10:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.794","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GPHN was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"GPHN","entity_type":"gene"},{"created":"2020-08-23T18:34:36.614341+10:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.793","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GPHN: Rating: GREEN; Mode of pathogenicity: None; Publications: 22040219, 11095995, 26613940, 24561070, 23393157; Phenotypes: Molybdenum cofactor deficiency C, MIM# 615501, Epilepsy, Autism, Intellectual disability; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"GPHN","entity_type":"gene"},{"created":"2020-08-23T18:34:01.096990+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3908","user_name":"Zornitza Stark","item_type":"entity","text":"Tag SV/CNV tag was added to gene: GPHN.","entity_name":"GPHN","entity_type":"gene"},{"created":"2020-08-23T18:33:49.327713+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3908","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GPHN were changed from  to Molybdenum cofactor deficiency C, MIM# 615501; Epilepsy; Autism; Intellectual disability","entity_name":"GPHN","entity_type":"gene"},{"created":"2020-08-23T18:33:04.003484+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3907","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GPHN were set to ","entity_name":"GPHN","entity_type":"gene"},{"created":"2020-08-23T18:32:47.549218+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3906","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GPHN was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"GPHN","entity_type":"gene"},{"created":"2020-08-23T18:32:31.159471+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3905","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GPHN: Rating: GREEN; Mode of pathogenicity: None; Publications: 22040219, 11095995, 26613940, 24561070, 23393157; Phenotypes: Molybdenum cofactor deficiency C, MIM# 615501, Epilepsy, Autism, Intellectual disability; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"GPHN","entity_type":"gene"},{"created":"2020-08-23T18:28:28.679660+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.53","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GPHN were changed from  to Molybdenum cofactor deficiency C, MIM# 615501","entity_name":"GPHN","entity_type":"gene"},{"created":"2020-08-23T18:27:31.302814+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.52","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GPHN was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"GPHN","entity_type":"gene"},{"created":"2020-08-23T18:26:43.207389+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.51","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: GPHN as Red List (low evidence)","entity_name":"GPHN","entity_type":"gene"},{"created":"2020-08-23T18:26:43.197795+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.51","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gphn has been classified as Red List (Low Evidence).","entity_name":"GPHN","entity_type":"gene"},{"created":"2020-08-23T18:26:03.382315+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.50","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GPHN: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Molybdenum cofactor deficiency C, MIM# 615501; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"GPHN","entity_type":"gene"},{"created":"2020-08-23T18:23:05.101681+10:00","panel_name":"Paroxysmal Dyskinesia","panel_id":259,"panel_version":"0.36","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GLRB as ready","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:23:05.093312+10:00","panel_name":"Paroxysmal Dyskinesia","panel_id":259,"panel_version":"0.36","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: glrb has been classified as Green List (High Evidence).","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:23:02.480108+10:00","panel_name":"Paroxysmal Dyskinesia","panel_id":259,"panel_version":"0.36","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GLRB were changed from  to Hyperekplexia 2, MIM# 614619","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:22:41.177302+10:00","panel_name":"Paroxysmal Dyskinesia","panel_id":259,"panel_version":"0.35","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GLRB were set to ","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:22:19.565786+10:00","panel_name":"Paroxysmal Dyskinesia","panel_id":259,"panel_version":"0.34","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GLRB was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:21:50.835662+10:00","panel_name":"Paroxysmal Dyskinesia","panel_id":259,"panel_version":"0.33","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GLRB: Rating: GREEN; Mode of pathogenicity: None; Publications: 21391991, 11929858, 27843043; Phenotypes: Hyperekplexia 2, MIM# 614619; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:21:13.794442+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3905","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GLRB as ready","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:21:13.786281+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3905","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: glrb has been classified as Green List (High Evidence).","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:21:07.458782+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3905","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GLRB were changed from  to Hyperekplexia 2, MIM# 614619","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:20:49.731959+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3904","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GLRB were set to ","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:20:33.261670+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3903","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GLRB was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:19:56.749487+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3902","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GLRB: Rating: GREEN; Mode of pathogenicity: None; Publications: 21391991, 11929858, 27843043; Phenotypes: Hyperekplexia 2, MIM# 614619; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:19:01.402853+10:00","panel_name":"Brain Channelopathies","panel_id":74,"panel_version":"0.27","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GLRB as ready","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:19:01.386327+10:00","panel_name":"Brain Channelopathies","panel_id":74,"panel_version":"0.27","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: glrb has been classified as Green List (High Evidence).","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:18:58.957805+10:00","panel_name":"Brain Channelopathies","panel_id":74,"panel_version":"0.27","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GLRB were changed from  to Hyperekplexia 2, MIM# 614619","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:18:36.084901+10:00","panel_name":"Brain Channelopathies","panel_id":74,"panel_version":"0.26","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GLRB were set to ","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:18:06.211219+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.50","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GLRB were set to 21391991; 11929858","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:17:41.442368+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.49","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: GLRB: Changed publications: 21391991, 11929858, 27843043","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:17:38.549775+10:00","panel_name":"Brain Channelopathies","panel_id":74,"panel_version":"0.25","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GLRB was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:17:10.947258+10:00","panel_name":"Brain Channelopathies","panel_id":74,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GLRB: Rating: GREEN; Mode of pathogenicity: None; Publications: 21391991, 11929858, 27843043; Phenotypes: Hyperekplexia 2, MIM# 614619; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:15:27.560258+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.49","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GLRB as ready","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:15:27.549681+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.49","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: glrb has been classified as Green List (High Evidence).","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:15:18.967162+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.49","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GLRB were changed from  to Hyperekplexia 2, MIM# 614619","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:14:53.838400+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.48","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GLRB were set to ","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:14:31.559153+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.47","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GLRB was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:14:05.418696+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.46","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GLRB: Rating: GREEN; Mode of pathogenicity: None; Publications: 21391991, 11929858; Phenotypes: Hyperekplexia 2, MIM# 614619; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"GLRB","entity_type":"gene"},{"created":"2020-08-23T18:12:17.574667+10:00","panel_name":"Paroxysmal Dyskinesia","panel_id":259,"panel_version":"0.33","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GLRA1 as ready","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:12:17.564537+10:00","panel_name":"Paroxysmal Dyskinesia","panel_id":259,"panel_version":"0.33","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: glra1 has been classified as Green List (High Evidence).","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:12:14.939944+10:00","panel_name":"Paroxysmal Dyskinesia","panel_id":259,"panel_version":"0.33","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GLRA1 were changed from  to Hyperekplexia 1, MIM# 149400","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:11:53.574496+10:00","panel_name":"Paroxysmal Dyskinesia","panel_id":259,"panel_version":"0.32","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GLRA1 were set to ","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:11:29.151607+10:00","panel_name":"Paroxysmal Dyskinesia","panel_id":259,"panel_version":"0.31","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GLRA1 was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:11:05.176336+10:00","panel_name":"Paroxysmal Dyskinesia","panel_id":259,"panel_version":"0.30","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GLRA1: Rating: GREEN; Mode of pathogenicity: None; Publications: 8298642, 16832093; Phenotypes: Hyperekplexia 1, MIM# 149400; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:10:20.528120+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3902","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GLRA1 was changed from MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:09:55.624702+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3901","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: GLRA1: Changed mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:09:30.990106+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3901","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GLRA1 as ready","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:09:30.979448+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3901","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: glra1 has been classified as Green List (High Evidence).","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:09:24.807430+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3901","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GLRA1 were changed from  to Hyperekplexia 1, MIM# 149400","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:09:09.680467+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3900","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GLRA1 were set to ","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:08:54.161518+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3899","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GLRA1 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:08:37.313740+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3898","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GLRA1: Rating: GREEN; Mode of pathogenicity: None; Publications: 8298642, 16832093; Phenotypes: Hyperekplexia 1, MIM# 149400; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:07:47.336033+10:00","panel_name":"Brain Channelopathies","panel_id":74,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GLRA1 as ready","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:07:47.326542+10:00","panel_name":"Brain Channelopathies","panel_id":74,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: glra1 has been classified as Green List (High Evidence).","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:07:44.844343+10:00","panel_name":"Brain Channelopathies","panel_id":74,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GLRA1 were changed from  to Hyperekplexia 1, MIM# 149400","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:07:24.152758+10:00","panel_name":"Brain Channelopathies","panel_id":74,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GLRA1 were set to ","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:07:01.759364+10:00","panel_name":"Brain Channelopathies","panel_id":74,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GLRA1 was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:06:40.613116+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.46","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GLRA1 were changed from  to Hyperekplexia 1, MIM# 149400","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:06:38.199025+10:00","panel_name":"Brain Channelopathies","panel_id":74,"panel_version":"0.21","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GLRA1: Rating: GREEN; Mode of pathogenicity: None; Publications: 8298642, 16832093; Phenotypes: Hyperekplexia 1, MIM# 149400; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:05:29.737405+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.45","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GLRA1 were set to ","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:05:10.512789+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.44","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GLRA1 was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:04:47.339594+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.43","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GLRA1: Rating: GREEN; Mode of pathogenicity: None; Publications: 8298642, 16832093; Phenotypes: Hyperekplexia 1, MIM# 149400; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"GLRA1","entity_type":"gene"},{"created":"2020-08-23T18:02:04.816060+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.43","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GCH1 as ready","entity_name":"GCH1","entity_type":"gene"},{"created":"2020-08-23T18:02:04.805806+10:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"0.43","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gch1 has been classified as Green List (High Evidence).","entity_name":"GCH1","entity_type":"gene"}]}